Breaking News, Collaborations & Alliances

NorthX Biologics, Demeetra Partner on Integrated Path from Gene to GMP

Collaboration links cell line development and GMP manufacturing to help biotechs reach IND milestones faster.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Demeetra’s CleanCut CHO platform combined with NorthX Biologics’ process development and GMP manufacturing capabilities supports stable, high-titer cell line development and a streamlined path to clinical material.

NorthX Biologics and Demeetra have announced a strategic collaboration. The goal is to help biotech companies move from gene to GMP manufacturing faster and with less risk. The partnership combines Demeetra’s CleanCut CHO platform and cell line development services with NorthX Biologics’ GMP manufacturing expertise. NorthX also provides process development, MCB banking, scale-up, and fill-finish services. Together, the companies offer a more direct path from early development to clinical m...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters